Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer

Condition:   Head and Neck Squamous Cell Carcinoma
Interventions:   Drug: Pembrolizumab;   Drug: Cisplatin;   Radiation: IMRT
Sponsors:   University of Pittsburgh;   Merck Sharp & Dohme Corp.
Recruiting - verified August 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/2c0i6jy
via IFTTT